Poop pills for painful skin? fecal transplant trial targets hidradenitis

NCT ID NCT07668713

Not yet recruiting Disease control Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether fecal microbiota transplantation (FMT) can improve moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Researchers will give 24 adults a single FMT and track changes in their skin lesions over 12 weeks. The goal is to see if altering gut bacteria can reduce inflammation and flare-ups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fecal microbiota transplantation (FMT)
What this could lead to: If it works, this could point toward a new treatment option for hidradenitis suppurativa by restoring healthy gut bacteria.
What could go wrong: This is a very early phase 1 pilot with only 24 participants, so results may not apply broadly. FMT carries risks of infection or digestive upset, and the effect on HS is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FECAL MICROBIOTA TRANSPLANTATION (FMT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FECAL MICROBIOTA TRANSPLANTATION (FMT) HIDRADENITIS SUPPURATIVA (HS)

Contacts and locations

Locations

CH Rodez

Rodez, France
CHU Bordeaux, Hôpital Saint-André

Bordeaux, France
CHU Clermont Ferrand

Clermont-Ferrand, France
CHU Clermont Ferrand, PIC/CIC

Clermont-Ferrand, France
CHU Lyon

Lyon, France
CHU Marseille, La Timone

Marseille, France
CHU Montpellier

Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.